Synthesis and biological activity of new pyridone diaryl ether non-nucleoside inhibitors of HIV-1 reverse transcriptase

被引：21

作者：

Kennedy-Smith, Joshua J. ^{[1
]}

Arora, Nidhi ^{[1
]}

Billedeau, J. Roland ^{[1
]}

Fretland, Jennifer ^{[5
]}

Hang, Julie Q. ^{[4
]}

Heilek, Gabrielle M. ^{[3
]}

Harris, Seth F. ^{[2
]}

Hirschfeld, Donald ^{[1
]}

Javanbakht, Hassan ^{[3
]}

Li, Yu ^{[4
]}

Liang, Weiling ^{[1
]}

Roetz, Ralf ^{[1
]}

Smith, Mark ^{[1
]}

Su, Guoping ^{[3
]}

Suh, Judy M. ^{[1
]}

Villasenor, Armando G. ^{[2
]}

Wu, Jeffrey ^{[1
]}

Yasuda, Dennis ^{[1
]}

Klumpp, Klaus ^{[4
]}

Sweeney, Zachary K. ^{[1
]}

机构：

[1] Roche Palo Alto, Dept Med Chem, Palo Alto, CA 94304 USA

[2] Roche Palo Alto, Dept Discovery Technol, Palo Alto, CA 94304 USA

[3] Roche Palo Alto, Dept Viral Dis Biol, Palo Alto, CA 94304 USA

[4] Roche Palo Alto, Dept Viral Dis Biochem, Palo Alto, CA 94304 USA

[5] Roche Palo Alto, Dept Nonclin Safety, Palo Alto, CA 94304 USA

来源：

MEDCHEMCOMM | 2010年 / 1卷 / 01期

关键词：

DISCOVERY;

D O I：

10.1039/c0md00009d

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

New pyridone non-nucleoside reverse transcriptase inhibitors (NNRTIs) were prepared and several flexible routes to this class of inhibitor were identified. These NNRTIs were active inhibitors of the replication of wild-type and NNRTI-resistant HIV. Structure-based drug design was used to optimize the activity of the compounds against NNRTI-resistant mutants. The co-crystal structure of inhibitor 2b in the NNIZTI binding pocket of HIV reverse transcriptase (HIVRT) is also described.

引用

页码：79 / 83

页数：5

共 50 条

[31] Optimization of benzyloxazoles as non-nucleoside inhibitors of HIV-1 reverse transcriptase to enhance Y181C potency
Bollini, Mariela
Gallardo-Macias, Ricardo
Spasov, Krasimir A.
Tirado-Rives, Julian
Anderson, Karen S.
Jorgensen, William L.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (04) : 1110 - 1113
[32] Indolylarylsulfones bearing phenylboronic acid and phenylboronate ester functionalities as potent HIV-1 non-nucleoside reverse transcriptase inhibitors
Xu, Shujing
Song, Shu
Sun, Lin
Gao, Ping
Gao, Shenghua
Ma, Yue
Kang, Dongwei
Cheng, Yusen
Zhang, Xujie
Cherukupalli, Srinivasulu
De Clercq, Erik
Pannecouque, Christophe
Liu, Xinyong
Zhan, Peng
BIOORGANIC & MEDICINAL CHEMISTRY, 2022, 53
[33] Design and synthesis of N1-aryl-benzimidazoles 2-substituted as novel HIV-1 non-nucleoside reverse transcriptase inhibitors
Monforte, Anna-Maria
Ferro, Stefania
De Luca, Laura
Lo Surdo, Giuseppa
Morreale, Francesca
Pannecouque, Christophe
Balzarini, Jan
Chimirri, Alba
BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (04) : 1459 - 1467
[34] Molecular Docking Study of Phthalimide Derivatives as Non-nucleoside HIV-1 Reverse Transcriptase Inhibitor
Maicheen, Chirattikan
Samee, Weerasak
Ungwitayatorn, Jiraporn
CHIANG MAI JOURNAL OF SCIENCE, 2017, 44 (04): : 1395 - 1406
[35] Structure-based virtual screening efforts against HIV-1 reverse transcriptase to introduce the new potent non-nucleoside reverse transcriptase inhibitor
Hosseini, Yaser
Mollica, Adriano
Mirzaie, Sako
JOURNAL OF MOLECULAR STRUCTURE, 2016, 1125 : 592 - 600
[36] Structural Basis of 2-Phenylamino-4-phenoxyquinoline Derivatives as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors
Makarasen, Arthit
Patnin, Suwicha
Vijitphan, Pongsit
Reukngam, Nanthawan
Khlaychan, Panita
Kuno, Mayuso
Intachote, Pakamas
Saimanee, Busakorn
Sengsai, Suchada
Techasakul, Supanna
MOLECULES, 2022, 27 (02):
[37] Novel piperidinylamino-diarylpyrimidine derivatives with dual structural conformations as potent HIV-1 non-nucleoside reverse transcriptase inhibitors
Chen, Xuwang
Liu, Xin
Meng, Qing
Wang, Ding
Liu, Huiqing
De Clercq, Erik
Pannecouque, Christophe
Balzarini, Jan
Liu, Xinyong
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (24) : 6593 - 6597
[38] Synthesis, molecular docking and biological evaluation of 2-(thiophen-2-yl)-1H-indoles as potent HIV-1 non-nucleoside reverse transcriptase inhibitors
El-Hussieny, Marwa
El-Sayed, Naglaa F.
Ewies, Ewies F.
Ibrahim, Nabila M.
Mahran, Mohamed R. H.
Fouad, Marwa A.
BIOORGANIC CHEMISTRY, 2020, 95
[39] Docking-based 3D-QSAR and pharmacophore studies on diarylpyrimidines as non-nucleoside inhibitors of HIV-1 reverse transcriptase
Liu, Genyan
Wan, Youlan
Wang, Wenjie
Fang, Sai
Gu, Shuangxi
Ju, Xiulian
MOLECULAR DIVERSITY, 2019, 23 (01) : 107 - 121
[40] Hybrid diarylbenzopyrimidine non-nucleoside reverse transcriptase inhibitors as promising new leads for improved anti-HIV-1 chemotherapy
Zeng, Zhao-Sen
He, Qiu-Qin
Liang, Yong-Hong
Feng, Xiao-Qing
Chen, Fen-Er
De Clercq, Erik
Balzarini, Jan
Pannecouque, Christophe
BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (14) : 5039 - 5047

← 1 2 3 4 5 →